Sagimet Biosciences (SGMT) Non-Current Assets (2022 - 2026)

Sagimet Biosciences' Non-Current Assets history runs 5 years deep, the most recent figure standing at $39000.0 for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 61.0% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $19.2 million, a 59.42% decrease from a year earlier, with the FY2025 full-year figure at $78000.0, down 98.96% from the prior year.
• Non-Current Assets declined to $39000.0 in Q1 2026 per SGMT's latest filing, from $78000.0 in the prior quarter.
• Across five years, Non-Current Assets topped out at $22.3 million in Q2 2024 and bottomed at $37000.0 in Q1 2024.
• The 5-year median for Non-Current Assets is $144000.0 (2023), against an average of $5.2 million.
• Across the five-year window, Non-Current Assets soared 16033.03% in 2024 and sank 98.96% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $239000.0 in 2022, then plunged by 69.46% to $73000.0 in 2023, then jumped by 10153.42% to $7.5 million in 2024, then sank by 98.96% to $78000.0 in 2025, then sank by 50.0% to $39000.0 in 2026.
• Per Business Quant, the three latest SGMT Non-Current Assets figures stand at $39000.0 (Q1 2026), $78000.0 (Q4 2025), and $8.9 million (Q3 2025).